US Stock MarketDetailed Quotes
TIL Instil Bio
- 28.3730
- +2.9430+11.57%
Trading Nov 27 12:58 ET
185.16MMarket Cap-2454P/E (TTM)
28.4900High25.5300Low51.91KVolume25.5300Open25.4300Pre Close1.42MTurnover2.17%Turnover RatioLossP/E (Static)6.53MShares92.000052wk High1.05P/B67.83MFloat Cap6.060052wk Low--Dividend TTM2.39MShs Float589.8000Historical High--Div YieldTTM11.64%Amplitude6.0600Historical Low27.2900Avg Price1Lot Size
Instil Bio Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -44.85%11.27M | -31.79%13.63M | -41.93%19.68M | -57.13%87.16M | -61.78%12.86M | -63.93%20.43M | -65.98%19.98M | -37.57%33.89M | 30.68%203.29M | -37.43%33.63M |
| Selling and administrative expenses | -10.33%10.71M | -7.05%10.71M | -6.04%12.42M | -23.59%47.55M | -15.79%10.87M | -29.71%11.94M | -33.13%11.52M | -12.51%13.22M | 28.83%62.24M | 15.53%12.91M |
| -General and administrative expense | -10.33%10.71M | -7.05%10.71M | -6.04%12.42M | -23.59%47.55M | -15.79%10.87M | -29.71%11.94M | -33.13%11.52M | -12.51%13.22M | 28.83%62.24M | 15.53%12.91M |
| Research and development costs | -93.38%562K | -65.47%2.92M | -64.90%7.26M | -71.92%39.6M | -90.43%1.98M | -78.59%8.49M | -79.62%8.46M | -47.24%20.67M | 31.52%141.06M | -51.33%20.72M |
| Operating profit | 44.85%-11.27M | 31.79%-13.63M | 41.93%-19.68M | 57.13%-87.16M | 61.78%-12.86M | 63.93%-20.43M | 65.98%-19.98M | 37.57%-33.89M | -30.68%-203.29M | 37.43%-33.63M |
| Net non-operating interest income expense | -213.87%-353K | -104.71%-80K | -94.36%81K | 106.38%3.66M | -79.54%215K | -33.90%310K | 994.84%1.7M | 1,379.38%1.44M | 2,115.00%1.77M | 2,902.86%1.05M |
| Non-operating interest income | -28.49%1.65M | -16.09%1.92M | -0.43%2.06M | 142.57%8.87M | 22.22%2.2M | 81.27%2.31M | 370.58%2.29M | 2,035.05%2.07M | 4,468.75%3.66M | 5,031.43%1.8M |
| Non-operating interest expense | 0.20%2.01M | 238.81%2M | 347.55%1.73M | 176.63%5.21M | 165.77%1.98M | 148.20%2M | 78.25%590K | --387K | --1.88M | --745K |
| Total other finance cost | ---- | ---- | 0.00%249K | ---- | ---- | ---- | ---- | --249K | ---- | ---- |
| Other net income (expense) | 75.91%-11.4M | -216.75%-1.21M | 80.89%-4.7M | -205.87%-72.59M | 98.70%-285K | -11,299.76%-47.31M | 62.98%-382K | -5,816.11%-24.61M | -1,761.25%-23.73M | -3,716.40%-21.87M |
| Special income (charges) | 73.29%-12.36M | 49.70%-508K | 82.59%-4.28M | -210.84%-72.01M | 99.29%-165K | ---46.28M | ---1.01M | ---24.55M | ---23.17M | ---23.17M |
| -Less：Restructuring and merger&acquisition | 307.32%167K | 1,915.38%262K | -65.42%1.26M | 210.84%72.01M | 194.85%68.31M | --41K | --13K | --3.65M | --23.17M | --23.17M |
| -Less:Impairment of capital assets | -95.25%2.2M | -75.33%246K | -85.59%3.01M | ---- | ---- | --46.24M | --997K | --20.9M | ---- | ---- |
| -Less:Other special charges | --10M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 193.86%963K | -211.78%-702K | -650.88%-428K | -1.95%-575K | -109.24%-120K | -147.23%-1.03M | 160.85%628K | 86.30%-57K | 55.76%-564K | 326.70%1.3M |
| Income before tax | 65.86%-23.02M | 20.07%-14.92M | 57.42%-24.3M | 30.70%-156.09M | 76.26%-12.93M | -19.15%-67.43M | 68.69%-18.66M | -4.51%-57.07M | -43.70%-225.25M | -0.29%-54.45M |
| Income tax | 0 | -5,415.38%-2.07M | -157.08%-605K | |||||||
| Net income | 65.86%-23.02M | 20.07%-14.92M | 57.42%-24.3M | 30.06%-156.09M | 76.00%-12.93M | -19.93%-67.43M | 68.37%-18.66M | -5.45%-57.07M | -42.34%-223.18M | 2.72%-53.84M |
| Net income continuous Operations | 65.86%-23.02M | 20.07%-14.92M | 57.42%-24.3M | 30.06%-156.09M | 76.00%-12.93M | -19.93%-67.43M | 68.37%-18.66M | -5.45%-57.07M | -42.34%-223.18M | 2.72%-53.84M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 65.86%-23.02M | 20.07%-14.92M | 57.42%-24.3M | 30.06%-156.09M | 76.00%-12.93M | -19.93%-67.43M | 68.37%-18.66M | -5.45%-57.07M | -42.34%-223.18M | 2.72%-53.84M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 65.86%-23.02M | 20.07%-14.92M | 57.42%-24.3M | 30.06%-156.09M | 76.00%-12.93M | -19.93%-67.43M | 68.37%-18.66M | -5.45%-57.07M | -42.34%-223.18M | 2.72%-53.84M |
| Basic earnings per share | 65.86%-3.54 | 20.21%-2.29 | 57.35%-3.74 | 30.35%-24 | 75.73%-1.99 | -20.58%-10.37 | 68.80%-2.87 | -4.40%-8.77 | -16.42%-34.46 | 4.65%-8.2 |
| Diluted earnings per share | 65.86%-3.54 | 20.21%-2.29 | 57.35%-3.74 | 30.35%-24 | 75.73%-1.99 | -20.58%-10.37 | 68.80%-2.87 | -4.40%-8.77 | -16.42%-34.46 | 4.65%-8.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data